Helen Branswell<p>Day 2 of <a href="https://scicomm.xyz/tags/ACIP" class="mention hashtag" rel="nofollow noopener noreferrer" target="_blank">#<span>ACIP</span></a> was almost eerily normal. ACIP recommended expanded use of adult RSV vaxes for people in their 50s at risk of severe disease, recommended a new chikungunya vax for some folks & a couple other things. But with no CDC director, not clear what's next. <a href="https://www.statnews.com/2025/04/16/cdc-acip-advisory-panel-recommends-expanded-rsv-and-two-new-vaccines/" rel="nofollow noopener noreferrer" translate="no" target="_blank"><span class="invisible">https://www.</span><span class="ellipsis">statnews.com/2025/04/16/cdc-ac</span><span class="invisible">ip-advisory-panel-recommends-expanded-rsv-and-two-new-vaccines/</span></a></p>